We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

11 hedge funds and large institutions have $431K invested in Aethlon Medical in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 → 11 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

29% less capital invested

Capital invested by funds: $604K → $431K (-$173K)

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$47.4K
2
AGM
Alpine Global Management
New York
+$40.6K
3
BlackRock
BlackRock
New York
+$13.5K
4
Osaic Holdings
Osaic Holdings
Arizona
+$13.5K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$34K
2
TSS
Two Sigma Securities
New York
-$27K
3
SPC
Sigma Planning Corp
Michigan
-$13.5K
4
UBS Group
UBS Group
Switzerland
-$6.77K

AEMD Hedge Fund Activity: Q3 2020 in Review

11 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2020, worth a combined $431K — down 29% from $604K a quarter earlier.

Fund positioning in AEMD was balanced in Q3 2020: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $47.4K. The largest seller was Jane Street, exiting entirely with an estimated $34K sold.

  • 11 institutional investors held Aethlon Medical (AEMD) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $431K of Aethlon Medical stock for Q3 2020, down 29% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q3 2020 and 3 closed out, a net change of 0 holders.
  • The largest Aethlon Medical buyer in Q3 2020 was Renaissance Technologies, an estimated $47.4K added.
  • The largest Aethlon Medical seller in Q3 2020 was Jane Street, an estimated $34K sold.

Based on aggregated 13F filings for Q3 2020.